WB
WuXi Biologics(2269.HK)
Wuxi, China
CDMO (Contract Manufacturing)Global biologics CDMO offering end-to-end solutions for antibody, ADC, fusion protein, and vaccine development and manufacturing.
Funding Stage
PUBLIC
Employees
10001-50000
Open Jobs
0
Pipeline & Clinical Trials
Bevacizumab in Combination With Paclitaxel/Carboplatin
NSCLCClinical Trials (1)
NCT02954172Evaluate the Efficacy and Safety of IBI305 in Patients With Advanced or Recurrent Non-squamous NSCLC
Phase 3Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Portfolio: 1 clinical trial